Earnings History Data for CohBar, Inc. (CWBR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

CohBar, Inc.

Cohbar, Inc. operates is a biotechnology company. It engaged in the research and development of mitochondria-based therapeutics for the treatment of diseases associated with aging. Cohbar, Inc. is based in Menlo Park, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-11-2022	AH	4:00 PM ET (Nov 8)	CWBR	CohBar, Inc.	6.27	-0.82	-1.02	-1.50	CohBar GAAP EPS of -$0.82 [11/8/2022 4:10 PM]	2.07	-0.20 (-8.81%)	0.0	0.0 (0.00%)	1.92 - 25.05	30,296	20,000	0
CohBar GAAP EPS of -$0.82 [11/8/2022 4:10 PM] CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress [Nov-08-22 04:03PM]
15-08-2022	AH	4:00 PM ET (Aug 15)	CWBR	CohBar, Inc.	16.08	-0.03	-0.04	-0.08	CohBar GAAP EPS of -$0.03 beats by $0.01 [8/15/2022 4:09 PM]	0.1791	-0.01 (-5.24%)	0.19	0.0 (-2.12%)	0.17 - 1.35	325,149	330,000	2,195
CohBar GAAP EPS of -$0.03 beats by $0.01 [8/15/2022 4:09 PM] CohBar Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress [Aug-15-22 04:02PM]
16-05-2022	AH	4:00 PM ET (May 16)	CWBR	CohBar, Inc.	16.94	-0.04	-0.03	-0.07	CohBar GAAP EPS of -$0.04 in-line [5/16/2022 4:07 PM]	0.1985	0.0 (0.00%)	0.21	0.0 (1.95%)	0.18 - 2.27	1,063,612	480,000	12,592
CohBar GAAP EPS of -$0.04 in-line [5/16/2022 4:07 PM] CohBar Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Progress [May-16-22 04:01PM]
29-03-2022	AH	4:00 PM ET (Mar 29)	CWBR	CohBar, Inc.	28.31	-0.04	0.00	-0.08	CohBar GAAP EPS of -$0.04 beats by $0.01 [3/29/2022 4:03 PM]	0.3159	-0.01 (-2.02%)	0.33	0.01 (2.39%)	0.24 - 2.27	304,384	550,000	6,280
CohBar GAAP EPS of -$0.04 beats by $0.01 [3/29/2022 4:03 PM] CohBar Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update [Mar-29-22 04:01PM]
15-11-2021	AH	4:00 PM ET (Nov 15)	CWBR	CohBar, Inc.	54.99	-0.05	-0.09	-0.04	CohBar EPS beats by $0.03 [11/15/2021 4:14 PM]	0.5943	-0.07 (-9.95%)	0.61	-0.05 (-7.58%)	0.55 - 2.27	3,856,702	3,870,000	188,533
CohBar EPS beats by $0.03 [11/15/2021 4:14 PM] CohBar Reports Third Quarter 2021 Financial Results and Provides Business Update [Nov-15-21 04:02PM]
10-08-2021	AH	4:00 PM ET (Aug 10)	CWBR	Cohbar Inc.	80.00	-0.08	-0.07	0.00		1.52	0.23 (17.83%)	1.98	0.69 (53.49%)	0.85 - 2.27	134,133,373	460,000	19,015,437
CohBar shares rise 10% on topline results from early-stage NASH study [8/10/2021 4:51 PM] CohBar Reports Second Quarter 2021 Financial Results and Provides Business Update [Aug-10-21 04:04PM] CohBar Announces Positive Topline Results from the Phase 1a/1b Study of CB4211 Under Development for NASH and Obesity [Aug-10-21 04:02PM]
17-05-2021	AH	4:00 PM ET (May 17)	CWBR	CohBar, Inc.	67.97	-0.07	-0.06	-0.06	CohBar EPS misses by $0.02 [5/17/2021 4:04 PM]	1.42	0.20 (16.39%)	1.17	-0.05 (-4.10%)	0.85 - 2.84	840,973	340,000	1,301
CohBar EPS misses by $0.02 [5/17/2021 4:04 PM] CohBar, Inc. to Host Earnings Call [May-17-21 03:15PM] CohBar Reports First Quarter 2021 Financial Results and Provides Business Update [May-17-21 04:02PM]
30-03-2021	AH	4:00 PM ET (Mar 30)	CWBR	CohBar, Inc.	83.12	-0.08	-0.05	-0.09	CohBar Q4 EPS misses by $0.03 [3/30/2021 4:05 PM]	1.36	0.10 (7.94%)	1.25	-0.01 (-0.79%)	0.85 - 4.25	307,983	520,000	14,778
CohBar Q4 EPS misses by $0.03 [3/30/2021 4:05 PM] CohBar Completes Enrollment in the Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity [Mar-29-21 09:00AM] CohBar, Inc. to Host Earnings Call [Mar-30-21 02:45PM] CohBar Reports Fourth Quarter 2020 Financial Results and Provides Business Update [Mar-30-21 04:02PM]
16-11-2020	AH	4:00 PM ET (Nov 16)	CWBR	CohBar, Inc.	59.70	-0.04	-0.05	-0.08	CohBar EPS in-line [11/16/2020 4:25 PM]	1.07	-0.08 (-6.96%)	1.12	-0.03 (-2.61%)	0.85 - 4.25	710,505	739,223	5,310

13-08-2020	AH	4:00 PM ET (Aug 13)	CWBR	CohBar, Inc.	70.80	-0.09	-0.06	-0.07	CohBar EPS misses by $0.03 [8/13/2020 4:11 PM]	1.47	-0.05 (-3.29%)	1.48	-0.04 (-2.63%)	0.87 - 4.25	194,325	574,062	826